8-K: Ryan Specialty Holdings Reports Strong Third Quarter Growth, Revenue Up 20.5%

Ryan Specialty Holdings announced a 20.5% year-over-year increase in total revenue for the third quarter of 2024, driven by organic growth and strategic acquisitions.

Summary

• Ryan Specialty Holdings reported a 20.5% increase in total revenue, reaching $604.7 million in the third quarter of 2024, compared to $501.9 million in the same period last year.
• The company's organic revenue growth rate was 11.8% for the quarter, slightly lower than the 15.0% reported in the prior-year period.
• Net income saw a significant increase of 82.4%, rising to $28.6 million, or $0.09 per diluted share, compared to $15.7 million in the prior year.
• Adjusted EBITDAC grew by 29.4% year-over-year to $190.3 million, with an adjusted EBITDAC margin of 31.5%.
• Adjusted net income increased by 31.2% to $113.6 million, or $0.41 per diluted share.
• The company returned $19.0 million to shareholders and LLC unit holders through regular dividends and distributions.
• Ryan Specialty closed five acquisitions through the beginning of October, enhancing their market position.
• The company is maintaining its full year 2024 outlook for organic revenue growth between 13.0% and 14.0% and adjusted EBITDAC margin between 32.0% and 32.5%.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to strong financial results, including significant revenue and profit growth, and strategic acquisitions. The company's maintained outlook and dividend declaration further support a positive outlook.

Positives

• Ryan Specialty experienced strong revenue growth across most of its property and casualty lines.
• The company's adjusted EBITDAC margin expanded by 220 basis points year-over-year.
• The leadership transition to Tim Turner as CEO has been seamless.
• The company strengthened its balance sheet by issuing new senior notes and upsizing its credit facility, while reducing its borrowing margin.
• The company's performance was outstanding across all of its specialties.
• The company is well positioned to deliver sustainable and differentiated growth over the long term.

Negatives

• The organic revenue growth rate of 11.8% was lower than the 15.0% reported in the prior-year period.
• Total operating expenses increased by 21.1%, primarily due to higher compensation and benefits expenses.
• General and administrative expenses also increased to accommodate revenue growth and acquisition-related expenses.
• Interest expense, net, and other non-operating losses were higher compared to the prior-year period.

Risks

• The company's forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from expectations.
• These risks include the ability to achieve objectives with its program, the costs associated with restructuring initiatives, and the ability to realize expected savings and benefits.
• Other risks include those associated with acquisitions, divestitures, joint ventures, strategic investments, legal and regulatory matters, and changes in legislation or regulations.
• The company's inability to provide a comparable outlook for total revenue growth rate or net income margin is due to the difficulty in forecasting the timing of certain items.

Future Outlook

The company is maintaining its full year 2024 outlook for organic revenue growth between 13.0% and 14.0% and adjusted EBITDAC margin between 32.0% and 32.5%.

Management Comments

• Patrick G. Ryan, Founder and Executive Chairman, stated it was an excellent quarter for Ryan Specialty by all measures, highlighting the 20.5% revenue growth and 11.8% organic revenue growth.
• Patrick G. Ryan also noted the expansion of the Adjusted EBITDAC margin by 220 basis points and the 28% growth in Adjusted EPS.
• Tim Turner, Chief Executive Officer, mentioned the outstanding performance from all of their specialties and the value delivered to clients in a difficult insurance market.
• Tim Turner also highlighted the addition of new teammates from five delegated authority businesses and the strengthening of the balance sheet.

Industry Context

The results reflect a strong performance in the specialty insurance market, with Ryan Specialty leveraging both organic growth and strategic acquisitions to expand its market presence. The company's focus on innovative solutions and value delivery aligns with the broader industry trend of seeking specialized expertise in a complex insurance landscape.

Comparison to Industry Standards

• Ryan Specialty's 20.5% revenue growth is strong compared to industry peers, many of whom are experiencing slower growth due to market conditions.
• The 11.8% organic revenue growth, while slightly down from the previous year, still indicates a healthy underlying business performance, outperforming many competitors in the insurance brokerage sector.
• The 29.4% growth in Adjusted EBITDAC and 31.2% growth in Adjusted Net Income are also impressive, suggesting strong operational efficiency and profitability compared to industry averages.
• Companies like Brown & Brown and Aon, which are also large insurance brokers, have reported varying growth rates, but Ryan Specialty's focus on specialty lines appears to be a key differentiator.
• The adjusted EBITDAC margin of 31.5% is competitive, indicating effective cost management and profitability compared to other insurance brokers.

Stakeholder Impact

• Shareholders will benefit from the increased profitability and the declared quarterly dividend.
• Employees may benefit from the company's growth and expansion.
• Customers will benefit from the company's innovative solutions and value delivery.
• The company's strong financial position may positively impact its relationships with suppliers and creditors.

Next Steps

• The company will continue to execute its M&A strategy.
• Ryan Specialty will host a conference call to discuss these results.
• The company will continue to focus on delivering sustainable and differentiated growth.

Key Dates

Keywords

insurance, specialty insurance, wholesale brokerage, underwriting management, organic growth, acquisitions, EBITDAC, revenue, dividends, financial results